Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
Journal of STEM Outreach
|
March 13, 2023
Getting to YES: The Evolution of the University of Pittsburgh Medical Center Hillman Cancer Center Youth Enjoy Science (YES) Academy
Joseph C Ayoob, Richard D Boyce, Solomon Livshits, et al.
Nature Communications
|
January 27, 2022
Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities
Nicola Cosgrove, Damir Varešlija, Stephen Keelan, et al.
Biorxiv : the Preprint Server for Biology
|
September 25, 2023
WCRC-25: A novel luminal Invasive Lobular Carcinoma cell line model
Ashuvinee Elangovan, Emily A Bossart, Ahmed Basudan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 23, 2024
Spatial molecular profiling of mixed invasive ductal and lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutations
Osama Shiraz Shah, Azadeh Nasrazadani, Julia Foldi, et al.
Biorxiv : the Preprint Server for Biology
|
June 25, 2024
Spatial molecular profiling of mixed invasive ductal-lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutations
Osama Shiraz Shah, Azadeh Nasrazadani, Julia Foldi, et al.
Cancer Cell
|
September 13, 2011
An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymoma
Jennifer M Atkinson, Anang A Shelat, Angel Montero Carcaboso, et al.
Nature Communications
|
April 20, 2022
ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation
Zheqi Li, Olivia McGinn, Yang Wu, et al.
Biorxiv : the Preprint Server for Biology
|
November 1, 2024
Systemic and local chronic inflammation and hormone disposition promote a tumor-permissive environment for breast cancer in older women
Neil Carleton, Sanghoon Lee, Ruxuan Li, et al.
Nature Cancer
|
June 27, 2025
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2<sup>+</sup> breast cancer that limits trastuzumab deruxtecan efficacy
Dong Hu, Xiaoshuang Lyu, Zheqi Li, et al.
Cancer Research
|
January 26, 2022
Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis
Zheqi Li, Yang Wu, Megan E Yates, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
Journal of STEM Outreach
|
March 13, 2023
Getting to YES: The Evolution of the University of Pittsburgh Medical Center Hillman Cancer Center Youth Enjoy Science (YES) Academy
Joseph C Ayoob, Richard D Boyce, Solomon Livshits, et al.
Nature Communications
|
January 27, 2022
Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities
Nicola Cosgrove, Damir Varešlija, Stephen Keelan, et al.
Biorxiv : the Preprint Server for Biology
|
September 25, 2023
WCRC-25: A novel luminal Invasive Lobular Carcinoma cell line model
Ashuvinee Elangovan, Emily A Bossart, Ahmed Basudan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 23, 2024
Spatial molecular profiling of mixed invasive ductal and lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutations
Osama Shiraz Shah, Azadeh Nasrazadani, Julia Foldi, et al.
Biorxiv : the Preprint Server for Biology
|
June 25, 2024
Spatial molecular profiling of mixed invasive ductal-lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutations
Osama Shiraz Shah, Azadeh Nasrazadani, Julia Foldi, et al.
Cancer Cell
|
September 13, 2011
An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymoma
Jennifer M Atkinson, Anang A Shelat, Angel Montero Carcaboso, et al.
Nature Communications
|
April 20, 2022
ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation
Zheqi Li, Olivia McGinn, Yang Wu, et al.
Biorxiv : the Preprint Server for Biology
|
November 1, 2024
Systemic and local chronic inflammation and hormone disposition promote a tumor-permissive environment for breast cancer in older women
Neil Carleton, Sanghoon Lee, Ruxuan Li, et al.
Nature Cancer
|
June 27, 2025
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2<sup>+</sup> breast cancer that limits trastuzumab deruxtecan efficacy
Dong Hu, Xiaoshuang Lyu, Zheqi Li, et al.
Cancer Research
|
January 26, 2022
Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis
Zheqi Li, Yang Wu, Megan E Yates, et al.
Page
of 4